Company news

NATCO Pharma Limited news in 2022

NATCO Pharma Limited's news releases, calls and decks from 2022, newest first.

View company

Press Release Dec 05 2022

December 5, 2022

Press Release Nov 16 2022

November 16, 2022

Press Release Nov 12 2022

November 12, 2022

Press Release Nov 09 2022

November 9, 2022

Press Release Oct 21 2022

October 21, 2022

Press Release Oct 04 2022

October 4, 2022

Press Release Sep 24 2022

September 24, 2022

Press Release Sep 19 2022

September 19, 2022

Press Release Aug 17 2022

August 17, 2022

NATCO records INR 918.9 Crore consolidated revenue and INR 320.4 Crore of profit, after tax, for the First Quarter, FY2022-23

August 10, 2022

Press Release Jul 25 2022

July 25, 2022

NATCO Announces Launch of First Generic Version of Nexavar (Sorafenib) Tablets in the U.S. Market

June 2, 2022

Press Release Jun 01 2022

June 1, 2022

NATCO records INR 2043.8 Crore consolidated revenue and INR 170.0 Crore of profit, after tax, for the year ended March 31' 2022

May 31, 2022

NATCO Announces Launch of the First Generic Version of Revlimid (Lenalidomide capsules), in the U.S. market

March 8, 2022

Press Release Mar 07 2022

March 7, 2022

NATCO announces License Agreement with the Medicines Patent Pool

January 21, 2022

Press Release Jan 20 2022

January 20, 2022

Press Release Jan 07 2022

January 7, 2022

Press Release Jan 01 2022

January 1, 2022

Decks in 2022